創薬インフォマティクスの世界市場規模、シェア、成長分析、ワークフロー別、モード別、サービス別 - 産業予測、2024年

創薬インフォマティクスの世界市場規模は、2022年に29億6,000万米ドルと評価され、予測期間（2024年～2031年）のCAGRは11.30%で、2023年の32億9,000万米ドルから77億6,000万米ドルへと成長する見通しです。

インシリコモデリング技術の使用頻度が高まっていること、医薬品開発データが増加していること、高性能コンピューティングとオンラインサービスが高度化していること、新規医薬品部位に対するニーズが高まっていること。これらの要因により、創薬インフォマティクス市場は今後数年間で上昇に転じると予想されます。充実した創薬情報技術のイントロダクションより、業界の競争は激化すると予想されます。例えば、2021年1月、Certara, Inc.はSimcyp Physiologically-based Pharmacokinetic（PBPK）Simulationプラットフォームのバージョン20を発表しました。この新しいモデルは、妊娠・授乳期における医薬品使用の評価・分析を容易にします。

さらに、医薬品の安全性と有効性の特性を最大化するための重要な選択を支援します。医薬品開発にかかる時間を短縮するため、企業はますますインフォマティクス技術を採用するようになっています。例えば、Curve Therapeutics Ltd.は、2021年にCDD Vaultプラットフォームを使用して、生物学的に符号化されたMicrocycleプラットフォームを管理する予定です。同プラットフォームは、学術機関、バイオテクノロジー企業、製薬業界が、安全で簡単なリアルタイムのデータ共有により共同発見を促進するために使用する人気のホスト型プラットフォームです。

さらに、世界のCOVID-19創薬プロセスはより迅速に進んでおり、これが市場拡大に拍車をかけています。例えば、研究者は迅速な治療法を提供するために、ヒトACE2受容体やウイルス・タンパク質を標的とするDrugBankの医薬品を用いたバーチャル・スクリーニングを採用しました。これらの研究では、抗COVID-19薬の探索に有用な微小分子のスクリーニングにシリコ・アプローチが用いられています。

これと同様に、企業はCOVID-19医薬品開発のさまざまな段階をサポートするために、デジタル・サービスやソリューションの数々を生み出しています。例えば、IBM Visual Molecular Explorerプラットフォームは、コロナウイルス（SARS-CoV-2）に対して作られた化学物質の一部を調べた。最適な薬剤設計の初期段階は、AIが生成した成果物をオープンソースで共有するエクスプローラーによって促進されました。

目次

エグゼクティブサマリー

• 市場概要
• 運命の輪

調査手法

• 情報調達
• セカンダリおよびプライマリデータソース
• 市場規模の推定
• 市場の前提条件と制限

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主な市場の考察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーションマトリクス
• パイプライン製品の分析
• マクロ経済指標
• 主な投資の分析
• 主な成功要因
• 競合の程度

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制情勢
• ポーターの分析
• 将来の混乱についての特別な考察

創薬インフォマティクスの世界市場：ワークフロー別

• 市場概要
• 発見情報学と開発情報学

創薬インフォマティクスの世界市場：モード別

• 市場概要
• 外部委託
• 社内

創薬インフォマティクスの世界市場：サービス別

• 市場概要
• 配列解析プラットフォーム
• 分子モデリング
• ドッキング
• 臨床試験データ管理
• その他のサービス

創薬インフォマティクスの世界市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2021年）
• 主な市場企業が採用した戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア（2021年）

主要企業プロファイル

• Accelrys（Biovia）
• SchrAﾂｶdinger
• Genedata
• OpenEye Scientific Software
• Certara
• Dotmatics
• Collaborative Drug Discovery（CDD）
• Optibrium
• Chemical Computing Group（CCG）
• IBM Watson Health
• PerkinElmer
• BioSolveIT
• Entelos
• Dassault SystAﾂｨmes Biovia
• XtalPi Inc.
• OpenText
• Benchling
• MedChemica Ltd.
• ChemAxon
• BioSymetrics Inc.

Global Drug Discovery Informatics Market size was valued at USD 2.96 Billion in 2022 and is poised to grow from USD 3.29 Billion in 2023 to USD 7.76 Billion, at a CAGR of 11.30 % during the forecast period (2024-2031).

In-silico modeling techniques are being used more often, drug development data is increasing, high-performance computing and online services are becoming more advanced, and there is a growing need for novel pharmaceutical moieties. These factors are expected to propel the drug discovery informatics market upward in the upcoming years. It is anticipated that industry competition would increase with the introduction of enhanced drug discovery information technology. For instance, in January 2021, Certara, Inc. launched version 20 of their Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulation platform. The new models facilitate the evaluation and analysis of pharmaceutical use during the course of pregnancy and lactation.

Moreover, it helps clients make important choices that maximize the safety and efficacy characteristics of drugs. Businesses are increasingly adopting informatics technology in an effort to shorten the time it takes to conduct drug development. For instance, Curve Therapeutics Ltd. will use the CDD Vault platform in 2021 to manage its biologically encoded Microcycle platform. It is a popular hosted platform used by academic institutions, biotechnology companies, and the pharmaceutical industry for safe, easy, real-time data sharing that fosters cooperative discoveries.

Additionally, the global Covid-19 drug discovery process is moving more quickly, which is fueling market expansion. For instance, researchers employed virtual screening using medications from the DrugBank to target human ACE2 receptors and viral proteins in order to deliver prompt remedies. These studies used silico approaches to screen for tiny molecules that could be useful in the search for anti-Covid-19 drugs.

In a same vein, businesses are creating an array of digital services and solutions to support the many phases of Covid-19 drug development. The IBM Visual Molecular Explorer platform, for instance, looked into a portion of the chemicals made that were directed against the coronavirus (SARS-CoV-2). The early phases of optimal drug design were facilitated by the explorer's open-source sharing of AI-generated artifacts.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Informatics Market Segmental Analysis

The global drug discovery informatics market is segmented based on workflow, mode, services, application, end-use, and region. In terms of workflow, the market is segmented into discovery informatics, and development informatics. On the basis of categorization by mode, the market is segmented into outsourced, and in-house. Based on services, the market is segmented into sequence analysis platforms, molecular modeling, docking, clinical trial data management, and other services. Based on region the global drug discovery informatics market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Drug Discovery Informatics Market

The demand for innovative pharmaceuticals has increased as a result of the rising prevalence of various diseases and the necessity for efficient treatment options. By facilitating effective data analysis, predictive modeling, and virtual screening, drug discovery informatics significantly contributes to the acceleration of the drug development process and consequently drives market growth.

Restraints in the Global Drug Discovery Informatics Market

Software licensing, hardware infrastructure, and trained staff are only a few of the significant upfront expenditures associated with implementing drug discovery informatics systems and technologies. Market expansion may be hindered by these high implementation costs, which may be an impediment for smaller businesses or organizations with tighter budgets.

Market Trends of the Global Drug Discovery Informatics Market

Growing Adoption of Machine Learning and Artificial Intelligence (AI and ML): In order to improve accuracy and efficiency, drug discovery informatics is incorporating AI and ML technologies more and more. Advanced data analysis, predictive modeling, and virtual screening are made possible by these technologies, which speed up the drug discovery process and increase success rates.

Growing Need for Cloud-Based Informatics Solutions: The drug discovery informatics industry has seen a notable increase in the use of cloud computing. With the scalability, flexibility, and affordability of cloud-based informatics solutions, businesses can effectively handle, store, and analyze massive amounts of data. They also make it easier for research teams to share data and collaborate remotely, which increases acceptance.

Emphasis on Targeted Therapies and customized Medicine: The market for drug discovery informatics has been impacted by the move toward targeted therapies and customized medicine. In order to find particular biomarkers, analyze patient data, and create customized treatments, informatics solutions are essential. Informatics tools for tailored drug discovery are being developed in response to the increasing focus on precision medicine.

Integration of Big Data Analytics: Big data analytics has been integrated into drug discovery informatics as a result of the availability of extensive genomic, proteomic, and clinical data. Researchers can uncover new therapeutic targets, get insightful knowledge, and streamline the drug development process by utilizing advanced analytics approaches including data mining, pattern recognition, and predictive modeling.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Drug Discovery Informatics Market by Workflow

• Market Overview
• Discovery Informatics and Development Informatics

Global Drug Discovery Informatics Market by Mode

• Market Overview
• Outsourced
• and In-house

Global Drug Discovery Informatics Market by Services

• Market Overview
• Sequence Analysis Platforms
• Molecular Modeling
• Docking
• Clinical Trial Data Management
• and Other Services

Global Drug Discovery Informatics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Accelrys (Biovia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SchrA¶dinger
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenEye Scientific Software
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dotmatics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collaborative Drug Discovery (CDD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optibrium
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemical Computing Group (CCG)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSolveIT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Entelos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault SystA¨mes Biovia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XtalPi Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenText
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchling
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedChemica Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChemAxon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSymetrics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments